{"id":2474,"date":"2012-10-25T21:05:43","date_gmt":"2012-10-26T01:05:43","guid":{"rendered":"http:\/\/www.kayak2u.com\/blog\/?p=2474"},"modified":"2012-10-25T21:05:43","modified_gmt":"2012-10-26T01:05:43","slug":"collective-guinea-pigs","status":"publish","type":"post","link":"http:\/\/www.kayak2u.com\/?p=2474","title":{"rendered":"Collective guinea pigs"},"content":{"rendered":"<p>It&#39;ll be like, you know, the draft:<\/p>\n<blockquote>\n<p><a href=\"http:\/\/virtualmentor.ama-assn.org\/2012\/01\/pfor1-1201.html\" target=\"_blank\">Should Participation in Vaccine Clinical Trials be Mandated?<\/a><\/p>\n<p>[&#8230;]<\/p>\n<p>In recent decades there has been a distressing decline in the numbers of healthy volunteers who participate in clinical trials [7], a decline that has the potential to become a key rate-limiting factor in vaccine development. Reasons for this decline are unclear but are likely to be multifaceted. One familiar problem is the payment of volunteers [8]. To date, the relatively meagre compensation that participants often receive could be seen to belittle and undervalue the contribution of these individuals to global health. The modest financial remuneration commonly provided often means that students and the unemployed make up the bulk of volunteers [6, 8, 9]. As a result, the risks of developing a health intervention that would benefit the whole population are carried disproportionately by some of society&rsquo;s most poor and vulnerable. This is a situation few would judge to be fair or ethical. However it is hard to increase volunteer payment without creating financial incentives. &ldquo;Danger money&rdquo; is frowned upon as an inducement that inevitably clouds an individual&rsquo;s appreciation of risk, limiting the likelihood that consent is informed [6, 7]. As a result, consensus has generally dictated that payment for volunteers&rsquo; trial involvement be modest and limited to compensation for travel, time, and inconvenience only.<\/p>\n<p>If progression of promising vaccines from the lab to the clinic is to remain unaffected and financial inducement is an ethically unacceptable solution to the recruitment shortage, other strategies need to be considered. Compulsory involvement in vaccine studies is one alternative solution that is not as outlandish as it might seem on first consideration. Many societies already mandate that citizens undertake activities for the good of society; in several European countries registration for organ-donation has switched from &ldquo;opt-in&rdquo; (the current U.S. system) to &ldquo;opt-out&rdquo; systems (in which those who do not specifically register as nondonors are presumed to consent to donation) [10], and most societies expect citizens to undertake jury service when called upon. In these examples, the risks or inconvenience to an individual are usually limited and minor. Mandatory involvement in vaccine trials is therefore perhaps more akin to military conscription, a policy operating today in 66 countries. In both conscription and obligatory trial participation, individuals have little or no choice regarding involvement and face inherent risks over which they have no control, all for the greater good of society.<\/p>\n<p>As ever, then, the debate boils down to a consideration of the &ldquo;greater good&rdquo; or the &ldquo;lesser evil.&rdquo; A key consideration is the risk benefit ratio&mdash;risk to the individual volunteer balanced against the benefit to society. Society is unlikely to accept compulsory recruitment to a trial for a vaccine against the common cold if the vaccine causes severe complications in vaccinees. Increase the severity of the disease in question, however, and compulsory recruitment becomes a more palatable option.<\/p>\n<\/blockquote>\n<p>I&#39;d expect that members of the AMA would be exempt from mandatory participation, as their contributions to society are too valuable to risk losing.<\/p>\n<p>It makes you wonder about people, don&#39;t it?<\/p>\n","protected":false},"excerpt":{"rendered":"<p>It&#39;ll be like, you know, the draft: Should Participation in Vaccine Clinical Trials be Mandated? [&#8230;] In recent decades there has been a distressing decline in the numbers of healthy volunteers who participate in clinical trials [7], a decline that has the potential to become a key rate-limiting factor in vaccine development. Reasons for this [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-2474","post","type-post","status-publish","format-standard","hentry","category-commies"],"_links":{"self":[{"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/posts\/2474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2474"}],"version-history":[{"count":0,"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/posts\/2474\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2474"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.kayak2u.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}